QQ客服 官方微博 反馈留言

浏览/检索结果: 共8条，第1-8条 帮助 限定条件 发表日期：2018     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Non-coordination planer cis-and trans-configuration of cis-[Pt(II)(mixed-NH3/RNH2)(3-OH-cyclobutane-1,1-dicarboxylate)]: separation, characterization, and anticancer activity 期刊论文 RESEARCH ON CHEMICAL INTERMEDIATES, 2018, 卷号: 44, 期号: 11, 页码: 6479-6487 作者:  Jiang, Jing;  Qiu, Jie;  Lou, Liguang;  Gao, Anli;  Hou, Shuqian 收藏  |  浏览/下载：22/0  |  提交时间：2019/01/08 Platinum(II) complexes  Anticancer activity  3-OH-cyclobutane-1  1-dicarboxylate  Mixed-NH3/RNH2  Non-coordination planer cis-  trans-isomerism   Pharmacological characterization of hetrombopag, a novel orally active human thrombopoietin receptor agonist 期刊论文 JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2018, 卷号: 22, 期号: 11, 页码: 5367-5377 作者:  Xie, Chengying;  Zhao, Huajun;  Bao, Xubin;  Fu, Haoyu;  Lou, Liguang 收藏  |  浏览/下载：34/0  |  提交时间：2019/01/08 eltrombopag  hetrombopag  hollow-fibre assay  thrombopoietin  thrombopoietin receptor   STAT3 activation confers trastuzumab-emtansine (T-DM1) resistance in HER2-positive breast cancer 期刊论文 CANCER SCIENCE, 2018, 卷号: 109, 期号: 10, 页码: 3305-3315 作者:  Wang, Lei;  Wang, Quanren;  Gao, Mingzhao;  Fu, Li;  Li, Yun 收藏  |  浏览/下载：51/0  |  提交时间：2019/01/08 drug resistance  leukemia inhibitory factor receptor  secreted factor  STAT3  trastuzumab-emtansine   Preclinical characterization of anlotinib, a highly potent and selective vascular endothelial growth factor receptor-2 inhibitor 期刊论文 CANCER SCIENCE, 2018, 卷号: 109, 期号: 4, 页码: 1207-1219 作者:  Xie, Chengying;  Wan, Xiaozhe;  Quan, Haitian;  Zheng, Mingyue;  Fu, Li 收藏  |  浏览/下载：43/0  |  提交时间：2019/01/08 angiogenesis  anlotinib  tyrosine kinase inhibitor  VEGF  VEGFR2   DCZ3112, a novel Hsp90 inhibitor, exerts potent antitumor activity against HER2-positive breast cancer through disruption of Hsp9O-Cdc37 interaction 期刊论文 CANCER LETTERS, 2018, 卷号: 434, 页码: 70-80 作者:  Chen, Xiangling;  Liu, Peng;  Wang, Quanren;  Li, Yun;  Fu, Li 收藏  |  浏览/下载：35/0  |  提交时间：2019/01/08 Cdc37  DCZ3112  Geldanamycin  Hsp90  HER2-positive breast cancer   Pharmacologic characterization of CT-711, a novel dual inhibitor of ALK and c-Met 期刊论文 AMERICAN JOURNAL OF CANCER RESEARCH, 2018, 卷号: 8, 期号: 8, 页码: 1541-1550 作者:  Wang, Lei;  Gao, Mingzhao;  Tong, Mengya;  Xie, Chengying;  He, Ye 收藏  |  浏览/下载：151/0  |  提交时间：2019/01/08 CT-711  ALK  c-Met  crizotinib  antitumor activity  pharmacokinetics   Combined inhibition of PI3K delta and FLT3 signaling exerts synergistic antitumor activity and overcomes acquired drug resistance in FLT3-activated acute myeloid leukemia 期刊论文 CANCER LETTERS, 2018, 卷号: 420, 页码: 49-59 作者:  He, Ye;  Sun, Liping;  Xu, Yongping;  Fu, Li;  Li, Yun 收藏  |  浏览/下载：34/0  |  提交时间：2019/01/08 Acute myeloid leukemia  FLT3  PI3K delta  CAL101  Synergistic effect   pharmacokineticsanddispositionofanlotinibanoraltyrosinekinaseinhibitorinexperimentalanimalspecies 期刊论文 actapharmacologicasinica, 2018, 卷号: 039, 期号: 006, 页码: 1048 作者:  Zhong Chenchun;  Chen Feng;  Yang Junling;  Jia Weiwei;  Li Li 收藏  |  浏览/下载：6/0  |  提交时间：2020/07/01 酷氨酸  布置  动物种类  试验性  血浆蛋白质  相互作用  新陈代谢  CYP3A